Immunosenescence: emerging challenges for an ageing population

Immunology - Tập 120 Số 4 - Trang 435-446 - 2007
Danielle Aw1, Alberto B. Silva1, Donald B. Palmer1
1Royal Veterinary College, Host Response and Genes and Development Group, Department of Veterinary Basic Sciences, Royal College Street, London, United Kingdom

Tóm tắt

Summary

It is now becoming apparent that the immune system undergoes age‐associated alterations, which accumulate to produce a progressive deterioration in the ability to respond to infections and to develop immunity after vaccination, both of which are associated with a higher mortality rate in the elderly. Immunosenescence, defined as the changes in the immune system associated with age, has been gathering interest in the scientific and health‐care sectors alike. The rise in its recognition is both pertinent and timely given the increasing average age and the corresponding failure to increase healthy life expectancy. This review attempts to highlight the age‐dependent defects in the innate and adaptive immune systems. While discussing the mechanisms that contribute to immunosenescence, with emphasis on the extrinsic factors, particular attention will be focused on thymic involution. Finally, we illuminate potential therapies that could be employed to help us live a longer, fuller and healthier life.

Từ khóa


Tài liệu tham khảo

Pawelec G, 1999, Immunosenescence: impact in the young as well as the old?, Mech Ageing Dev, 108, 1

Office for National Statistics. Theme: Population.http://www.statistics.gov.uk/cci/nugget.asp?id=949 2005.

10.1634/stemcells.2005-0345

10.1038/ni0402-329

10.1038/nm0996-1011

10.1016/S0960-9822(06)00341-1

10.1084/jem.144.5.1204

10.1084/jem.157.5.1496

10.1182/blood-2005-12-010272

10.1073/pnas.0503280102

10.1038/nature05159

10.1016/j.coi.2005.07.013

10.1189/jlb.1103592

10.1016/S0047-6374(01)00285-8

10.1016/j.febslet.2005.02.055

10.1186/1742-4933-2-8

10.1016/j.exger.2004.06.009

10.1111/j.1474-9728.2004.00102.x

10.1016/S0047-6374(03)00017-4

10.1111/j.0105-2896.2005.00260.x

10.1111/j.1474-9728.2004.00103.x

10.1111/j.1474-9726.2005.00178.x

10.1016/S0264-410X(99)00495-8

10.1111/j.1474-9728.2004.00107.x

10.1016/S0531-5565(98)00076-X

10.1016/j.coi.2005.07.002

10.1146/annurev.immunol.23.021704.115830

10.4049/jimmunol.170.3.1267

10.4049/jimmunol.171.5.2326

10.4049/jimmunol.176.2.1007

10.1093/intimm/8.4.509

10.4049/jimmunol.161.5.2248

10.1016/0165-2478(94)00067-0

10.1084/jem.20040845

Stephan RP, 1997, Development of B cells in aged mice: decline in the ability of pro‐B cells to respond to IL‐7 but not to other growth factors, J Immunol, 158, 1598, 10.4049/jimmunol.158.4.1598

10.1016/j.exger.2003.07.003

10.1007/3-540-26363-2_6

10.4049/jimmunol.173.2.818

10.1016/S0047-6374(00)00157-3

10.1016/j.smim.2005.05.011

10.4049/jimmunol.175.10.6633

10.1111/j.0105-2896.2005.00263.x

10.1016/S0531-5565(98)00033-3

Kline GH, 1999, B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation, J Immunol, 162, 3342, 10.4049/jimmunol.162.6.3342

10.1385/IR:27:2-3:141

10.4049/jimmunol.168.10.5014

10.1093/intimm/12.6.915

LeMaoult J, 1997, Clonal expansions of B lymphocytes in old mice, J Immunol, 159, 3866, 10.4049/jimmunol.159.8.3866

10.1111/j.1600-065X.1997.tb01028.x

10.1016/0047-6374(93)90033-N

10.1016/S0047-6374(98)00051-7

10.1016/0047-6374(77)90040-9

10.1084/jem.144.4.1037

Nicoletti C, 1993, Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibodies from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae, J Immunol, 150, 543, 10.4049/jimmunol.150.2.543

10.1084/jem.183.3.959

10.1111/j.1365-2567.2004.02006.x

10.1016/S0047-6374(97)00153-X

10.1111/j.0001-2815.2004.00255.x

10.1002/jemt.10409

10.1016/S0140-6736(61)90693-6

10.1016/0167-5699(93)90248-J

10.1038/35095500

Godfrey DI, 1993, A developmental pathway involving four phenotypically and functionally distinct subsets of CD3–CD4–CD8– triple‐negative adult mouse thymocytes defined by CD44 and CD25 expression, J Immunol, 150, 4244, 10.4049/jimmunol.150.10.4244

10.1016/S0952-7915(97)80146-X

10.1016/S0952-7915(00)00209-0

10.1016/S0161-5890(01)00122-5

10.1046/j.1365-3083.2003.01206.x

10.1111/j.1365-3083.1985.tb01916.x

10.1172/JCI7558

10.1038/25374

10.1016/S1074-7613(00)80056-4

10.1038/ni1049

10.1073/pnas.0601040103

10.1016/j.immuni.2006.06.001

10.1093/intimm/dxf042

10.1006/cimm.1997.1148

10.3181/00379727-152-39321

10.1084/jem.192.9.1273

10.4049/jimmunol.173.1.245

10.1016/S0047-6374(97)01871-X

10.1002/(SICI)1521-4141(199806)28:06<1886::AID-IMMU1886>3.0.CO;2-M

10.1016/S0531-5565(01)00213-3

10.1016/S0264-410X(99)00498-3

10.4049/jimmunol.173.8.4867

10.1046/j.1365-3083.2002.01077.x

10.1073/pnas.83.15.5663

10.1016/j.smim.2005.05.006

10.1016/j.clim.2005.08.015

10.1210/endo.142.3.8032

10.4049/jimmunol.175.5.2982

10.4049/jimmunol.175.4.2741

10.1006/smim.1998.0148

10.1007/BF02890079

10.1186/1742-4933-1-5

10.1182/blood-2006-02-004531

10.1002/jemt.10410

10.1111/j.0105-2896.2005.00275.x

10.1111/j.1749-6632.1992.tb38685.x

10.1016/0167-5699(96)80543-3

10.1016/0047-6374(95)01597-S

10.1242/dev.127.8.1583

10.1155/1993/56290

10.1006/clin.1994.1023

10.1016/j.coi.2005.07.020

10.1126/science.276.5321.2057

10.1084/jem.20040437

10.1016/j.immuni.2006.05.001

10.4049/jimmunol.174.11.7446

10.1073/pnas.88.21.9503

10.1016/S0531-5565(96)00097-6

10.1006/excr.1993.1171

10.1038/nri1440

10.1016/j.coi.2005.07.019

10.1016/j.it.2004.05.006

10.1016/j.immuni.2006.06.003

10.1111/j.0105-2896.2005.00270.x

10.1053/j.seminhematol.2005.11.028

10.1097/01.TP.0000070167.81584.A2

10.1182/blood-2003-09-3344

10.1182/blood.V88.5.1887.1887

10.1182/blood.V98.7.2256

Plum J, 1993, Exogenous IL‐7 promotes the growth of CD3–CD4–CD8–CD44+CD25+/– precursor cells and blocks the differentiation pathway of TCR‐alpha beta cells in fetal thymus organ culture, J Immunol, 150, 2706, 10.4049/jimmunol.150.7.2706

10.1016/j.mad.2006.01.016

10.1182/blood.V91.1.75

10.1016/S0047-6374(01)00290-1

10.1182/blood.V96.1.9

10.1016/S1471-4914(02)02415-2

10.1146/annurev.immunol.18.1.529

10.1056/NEJM199910143411603

10.1016/j.jpedsurg.2004.07.020

10.1038/ni812

10.1016/S1074-7613(02)00321-7

10.1038/nature04813

10.1038/nature04850

10.1210/er.21.3.292

10.1210/er.21.4.412

10.1111/j.1365-2567.2006.02351.x

10.1002/1521-4141(200206)32:6<1550::AID-IMMU1550>3.0.CO;2-W

10.1097/00002030-200205240-00003

10.1016/j.exger.2006.08.010

10.1007/s10522-006-9061-7

10.1007/s10522-006-9059-1

10.1210/endo-125-2-1025

10.1016/0047-6374(89)90030-4

10.1016/0192-0561(92)90115-2

10.1182/blood.V95.6.2059

10.1016/j.jaci.2006.01.041